Tecan Group Ltd. is a Swiss company providing laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics for pharmaceutical and biotechnology companies, university research departments and diagnostic laboratories.
The company focuses on the development, production and distribution of automation and detection products for life science laboratories.
Founded in Switzerland, in 1980, the company has over 1200 employees, owns production and research and development sites in both North America and Europe, and maintains a sales and service network in 52 countries.
In 2016, Tecan generated sales of CHF 506 million. Registered shares of Tecan Group are traded on the SIX Swiss Exchange.
Engineers Heinz Abplanalp, Heini Maurer, Heinz Möckli and Gallus Blater founded Tecan on March 18, 1980, with the aim of developing measuring, analysis and laboratory automation devices. The first company office was in the home of the CEO, Heinz Abplanalp, in Hombrechtikon, Switzerland. Tecan soon also started to produce instruments for laboratory automation and environmental analysis. The first instruments were made in renovated barns, apartments and warehouses spread across the whole village of Hombrechtikon. In 1982, the company opened Tecan US in Chapel Hill, North Carolina, for sales and marketing in North America, and Tecan Production Corp. to manufacture for the US marketplace. Two years later, 48% of the share capital was taken over by the finance company Zelux. In 1985, Tecan entered the market with the Tecan Sampler 500 series, the first process-controlled and fully automated pipetting devices. Other products included pH-electrodes, the Tecan Plant SAP Extractor 400 and the Tecan RSP 5052.
Highest paying job titles at Tecan include Automation Engineer, Manufacturing Engineer, and Product Manager